Filing Flows › iBio (IBIO) › Q2 FY25
iBio (IBIO) Q2 FY25 earnings results (second quarter fiscal 2025)
10-Q filed Feb 10, 2025
iBio (IBIO) reported revenue of $200K for the second quarter fiscal 2025 (Q2 FY25).
Revenue$200K
Year over year—
Quarter over quarter—
Operating margin—
Net earnings−$4.4M
iBio, Q2 FY25: revenue $200K, net loss $4.4M, operating cash flow −$3.9M. The chart follows the revenue to costs, profit and cash.
| Q2 FY25 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $200K | — | — |
| Operating profit | −$4.4M | — | — |
| Net earnings | −$4.4M | — | — |
| Operating cash flow | −$3.9M | — | — |
What changed
Revenue was $200K in Q2 FY25.
Operating costs exceeded revenue by $4.4M, an operating margin of -2209.5%. The quarter ended with a net loss of $4.4M.
Operating cash flow was −$3.9M. Non-cash charges added back $127K of depreciation and amortization and $475K of share-based compensation. Capital expenditures of $1K exceeded it, leaving free cash flow of −$3.9M.
Questions
What was iBio's revenue in the second quarter fiscal 2025?
iBio (IBIO) reported revenue of $200K for the second quarter fiscal 2025 (Q2 FY25).
Source: iBio 10-Q on SEC EDGAR.